NEW YORK (GenomeWeb) – GenomeDx Biosciences has agreed to pay $1.99 million to settle charges that it improperly billed Medicare for its Decipher Biopsy prostate cancer genomic classifier, the US Attorney's Office for the Southern District of California announced on Monday.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.